3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Enrolling by invitation
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Leiomyoma
3
Inflammation
2
Frailty
2
Small Cell Lung Carcinoma
1
Radiodermatitis
1
Prostatic Neoplasms
1
Papillomavirus Infections
1
Low-Grade Intraepithelial Neoplasia of Cervix
1
Liver Neoplasms
1
Liver Cirrhosis
1
Fibrosis
1
Esophageal Neoplasms
1
Deglutition Disorders
1
Colonic Neoplasms
1
Carcinoma, Hepatocellular
1
Interventions
Blood Specimen Collection
7
Pentoxifylline
4
Liver Transplantation
4
Magnetic Resonance Spectroscopy
3
Tocopherols
2
Low-Level Light Therapy
2
High-Energy Shock Waves
2
tremelimumab
1
sonidegib
1
maltodextrin
1
epigallocatechin gallate
1
durvalumab
1
contrast agent BR1
1
bavituximab
1
apixaban
1
alpha-Tocopherol
1
Vitamin E
1
Vitamin D
1
User-Centered Design
1
Tenofovir
1
Surveys and Questionnaires
1
Sunitinib
1
Standard of Care
1
Spermine Synthase
1
Specimen Handling
1
Sorafenib
1
Sonazoid
1
Sodium Chloride
1
Sampling Studies
1
Restraint, Physical
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Fibrosis
×
epigallocatechin gallate
×
Clear all
NCT07149506
2025-09-08
OCTOPUS-RD
Universidad de Guanajuato
Phase 3
Enrolling by invitation
162 enrolled